IQVIA, a leading global provider of data, analytics, technology and services to the life sciences industry, and Salesforce, the #1 AI CRM, announced an expanded global strategic partnership to accelerate the development of Salesforce’s Life Sciences Cloud, a next-generation customer engagement platform for the global life sciences industry.
Building on...
Tempus, a leader in artificial intelligence and precision medicine, will present new data along with Pfizer at the AACR 2024 Annual Meeting. The abstract, titled “Analysis of HER2 prevalence by RNA expression across solid tumors,” found that by correlating HER2 protein levels by IHC/ISH and ERBB2 mRNA levels by...
Tempus, a leader in artificial intelligence and precision medicine, is broadly introducing its new Workspaces feature in the Lens platform. Workspaces is a private, coding-based cloud environment designed to unblock research and accelerate innovation. This new interface provides researchers a frictionless workflow for surfacing critical insights to power scientific...
Nucleai, a spatial AI biomarker company that deciphers cellular conversations and maps cellular interactions within tissue samples to predict therapeutic outcomes, will showcase its developments in cancer research and diagnostics at the American Association for Cancer Research (AACR) Annual Meeting in San Diego, California from April 5-10, 2024. Nucleai's...
Collaboration combines expertise in computational chemistry, artificial intelligence and machine learning, to help advance discovery and development of medicines for difficult-to-drug targets
Odyssey Therapeutics, Inc., a biotechnology company pioneering next-generation precision medicines, announced it has entered into a strategic research collaboration with Janssen Pharmaceutical NV, a Johnson & Johnson company, to...
Anivive Lifesciences, is set to unveil groundbreaking research at the upcoming World Vaccine Congress, where they will present findings on the development of the world's first systemic antifungal vaccine – A solution for both ends of the leash. The conference, taking place April 1-4, brings together leading experts and researchers from...
Manifold, an AI-powered clinical research platform, announced a $15 million Series A. Led by TQ Ventures, the funding round also includes new investors Calibrate Ventures and SK Ventures, notable founders and CEOs including healthcare leader Dr. Sachin H. Jain and existing investors including TTCER Partners. Built by industry veterans, Manifold's platform streamlines...
PhenoScope can cut drug development time and costs significantly, while delivering safer & more effective therapy for cancer patients
SimBioSys, a leading innovator in precision oncology, and General Inception (“GI”), a global company Igniter, announced a strategic partnership that aims to significantly reduce oncology drug development times and cut development...
Aurigene Pharmaceutical Services Limited , a contract research, development, and manufacturing services organization and a Dr. Reddy’s Laboratories company, introduces Aurigene.AI, an AI and ML-assisted platform for accelerating drug discovery projects from hit identification to candidate nomination.
Aurigene.AI combines advanced physics-based simulation, generative and predictive AI models, and CADD (Computer-Aided...
Ultivue, a market leader in quantitative proteomic biomarker detection and advanced spatial tissue profiling, is unveiling its spatial insights platform, STARVUE™, at the American Association for Cancer Research (AACR) Annual Meeting. STARVUE™ is the culmination of Ultivue's multi-year engineering efforts to bring the latest innovations in artificial intelligence and image data...
